Multivariate analysis of factors associated with persistent colesevelam treatment among patients with

Robert J Romanelli1, Angela Leahy, Trevor Jukes

  • 1Sutter Health, San Francisco, CA, USA.

Insights

Persistent colesevelam treatment is crucial for managing hypercholesterolemia. Factors like female sex, baseline LDL-C at goal, and ezetimibe use influence treatment persistence in real-world practice.

Area of Science:

  • Cardiology
  • Pharmacology
  • Real-world evidence

Background:

  • Persistent lipid-lowering therapy is vital for optimal cardiovascular outcomes.
  • Real-world data on colesevelam persistence and influencing factors are limited.

Purpose of the Study:

  • To investigate patient demographics and characteristics associated with persistent colesevelam treatment in clinical practice.
  • To identify factors impacting long-term adherence to colesevelam therapy.

Main Methods:

  • Retrospective cohort study of adult hypercholesterolemia patients initiating colesevelam (2004-2011).
  • Defined persistence as no >30-day gap in medication orders over 12 months.
  • Used multivariate logistic regression to analyze factors associated with persistence.

Main Results:

  • 49% of patients demonstrated persistent colesevelam treatment for ≥12 months.
  • Female sex was linked to lower persistence odds (OR=0.69).
  • Achieving baseline LDL-C goals and concurrent ezetimibe use increased persistence odds (OR=1.39 and OR=1.64, respectively).

Conclusions:

  • Identified key demographic and clinical factors influencing colesevelam treatment persistence.
  • Findings can inform strategies to enhance adherence and improve patient outcomes.
  • Real-world insights into colesevelam use are crucial for optimizing lipid management.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
479
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.9K